Short answer · Medically reviewed summary · Last updated: 2026-05-08
West Syndrome, also known as infantile spasms, was first described in 1841 by Dr. William James West, who observed the condition in his own son.
What is the history of West Syndrome?
History of West Syndrome: when and how it was discovered, and the milestones in research since, medically reviewed.
West Syndrome, also known as infantile spasms, was first described in 1841 by Dr. William James West, who observed the condition in his own son. While historically viewed as a hopeless diagnosis, modern medicine has transformed West Syndrome into a treatable condition where early identification and intervention significantly improve long-term neurodevelopmental outcomes.
Who first discovered West Syndrome?
The history of West Syndrome began in 1841 when Dr. William James West published a report in The Lancet describing his infant son, James Edwin West. He meticulously documented the "peculiar convulsive affection" characterized by sudden, repetitive forward flexion of the head and trunk. For over a century, the medical community struggled to understand the underlying causes of West Syndrome, often misdiagnosing it or failing to distinguish it from other childhood seizure disorders.
How has our understanding of West Syndrome evolved?
In the mid-20th century, the introduction of the electroencephalogram (EEG) revolutionized the study of West Syndrome. Researchers identified a signature, disorganized brain wave pattern known as "hypsarrhythmia," which is now a hallmark diagnostic criterion. Today, we understand that West Syndrome is not a single disease but an age-specific epileptic encephalopathy that can be triggered by diverse factors, including genetic mutations, structural brain abnormalities, or metabolic disorders.
What are the major milestones in treatment?
The management of West Syndrome has shifted from reactive care to rapid, aggressive intervention to protect the developing brain. Key milestones include:
- 1950s: The discovery that adrenocorticotropic hormone (ACTH) could effectively stop the spasms associated with West Syndrome.
- 1990s: The approval of vigabatrin, which remains a first-line therapy, particularly for patients with Tuberous Sclerosis Complex.
- Modern Era: The use of advanced genetic sequencing to identify precise underlying causes, allowing for more personalized, targeted treatment plans.
How did patient advocacy change the landscape?
Historically, parents of children with West Syndrome faced significant isolation. The rise of global platforms like DiseaseMaps.org, where 7 members have shared their journeys, has fostered a sense of community. Advocacy groups have successfully pushed for earlier screening and increased research funding, moving the narrative from one of "inevitable decline" to one of proactive management and support.
Next steps
- Consult a pediatric neurologist for an urgent EEG if you suspect infantile spasms.
- Connect with the West Syndrome community on DiseaseMaps.org to share experiences and coping strategies.
- Request genetic counseling to explore potential underlying causes for the condition.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Infantile Spasms
- Orphanet: West Syndrome (ORPHA: 887)
- OMIM (Online Mendelian Inheritance in Man): Infantile Spasms (Entry #308350)
- The Child Neurology Foundation: Infantile Spasms Resources
